{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "20487222", "DateCompleted": {"Year": "2010", "Month": "09", "Day": "10"}, "DateRevised": {"Year": "2015", "Month": "11", "Day": "19"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": ["10.1211/jpp.62.03.0013"], "Journal": {"ISSN": "2042-7158", "JournalIssue": {"Volume": "62", "Issue": "3", "PubDate": {"Year": "2010", "Month": "Mar"}}, "Title": "The Journal of pharmacy and pharmacology", "ISOAbbreviation": "J Pharm Pharmacol"}, "ArticleTitle": "Effects of morroniside isolated from Corni Fructus on renal lipids and inflammation in type 2 diabetic mice.", "Pagination": {"StartPage": "374", "EndPage": "380", "MedlinePgn": "374-80"}, "Abstract": {"AbstractText": ["The effects of morroniside isolated from Corni Fructus on renal lipids and inflammation provoked by hyperglycaemia were investigated using type 2 diabetic mice.", "Morroniside was administered orally to db/db mice at 20 or 100 mg/kg daily for 8 weeks, and its effects were compared with those in vehicle-treated db/db and m/m (non-diabetic) mice. Serum and renal biochemical factors and protein expression related to lipid homeostasis and inflammation were measured.", "Morroniside produced significant dose-dependent reductions in serum triglyceride and renal glucose and lipid levels. Morroniside altered the abnormal protein expression of sterol regulatory element binding proteins (SREBP-1 and SREBP-2). In addition, the formation of reactive oxygen species and lipid peroxidation were inhibited in the morroniside-treated db/db mouse group, and the ratio of reduced glutathione to the oxidised form was significantly elevated. These results suggest that morroniside alleviated oxidative stress in the kidneys of db/db mice. Furthermore, 100 mg/kg morroniside down-regulated the expression of nuclear factor-kappaBp65, cyclooxygenase-2 and inducible nitric oxide synthase augmented in db/db mice.", "Morroniside may inhibit abnormal lipid metabolism and inflammation due to reactive oxygen species in the kidneys in type 2 diabetes."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Natural Medicine, University of Toyama, Toyama, Japan."}], "Identifier": [], "LastName": "Park", "ForeName": "Chan Hum", "Initials": "CH"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Noh", "ForeName": "Jeong Sook", "Initials": "JS"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Tanaka", "ForeName": "Takashi", "Initials": "T"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Yokozawa", "ForeName": "Takako", "Initials": "T"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "J Pharm Pharmacol", "NlmUniqueID": "0376363", "ISSNLinking": "0022-3573"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Biomarkers"}, {"RegistryNumber": "0", "NameOfSubstance": "Glycosides"}, {"RegistryNumber": "0", "NameOfSubstance": "Sterol Regulatory Element Binding Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "Transcription Factor RelA"}, {"RegistryNumber": "0", "NameOfSubstance": "Triglycerides"}, {"RegistryNumber": "0", "NameOfSubstance": "morroniside"}, {"RegistryNumber": "EC 1.14.13.39", "NameOfSubstance": "Nitric Oxide Synthase Type I"}, {"RegistryNumber": "EC 1.14.13.39", "NameOfSubstance": "Nos1 protein, mouse"}, {"RegistryNumber": "EC 1.14.99.-", "NameOfSubstance": "Ptgs2 protein, mouse"}, {"RegistryNumber": "EC 1.14.99.1", "NameOfSubstance": "Cyclooxygenase 2"}, {"RegistryNumber": "IY9XDZ35W2", "NameOfSubstance": "Glucose"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["metabolism"], "DescriptorName": "Biomarkers"}, {"QualifierName": ["chemistry"], "DescriptorName": "Cornus"}, {"QualifierName": ["metabolism"], "DescriptorName": "Cyclooxygenase 2"}, {"QualifierName": [], "DescriptorName": "Diabetes Mellitus, Experimental"}, {"QualifierName": ["complications", "drug therapy", "metabolism"], "DescriptorName": "Diabetes Mellitus, Type 2"}, {"QualifierName": ["metabolism"], "DescriptorName": "Diabetic Nephropathies"}, {"QualifierName": [], "DescriptorName": "Dose-Response Relationship, Drug"}, {"QualifierName": ["chemistry"], "DescriptorName": "Fruit"}, {"QualifierName": ["metabolism"], "DescriptorName": "Glucose"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Glycosides"}, {"QualifierName": ["etiology", "metabolism"], "DescriptorName": "Inflammation"}, {"QualifierName": ["drug effects"], "DescriptorName": "Lipid Metabolism"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Mice, Inbred C57BL"}, {"QualifierName": ["metabolism"], "DescriptorName": "Nitric Oxide Synthase Type I"}, {"QualifierName": ["drug effects"], "DescriptorName": "Oxidative Stress"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["metabolism"], "DescriptorName": "Sterol Regulatory Element Binding Proteins"}, {"QualifierName": ["metabolism"], "DescriptorName": "Transcription Factor RelA"}, {"QualifierName": ["blood"], "DescriptorName": "Triglycerides"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2010", "Month": "5", "Day": "22", "Hour": "6", "Minute": "0"}, {"Year": "2010", "Month": "5", "Day": "22", "Hour": "6", "Minute": "0"}, {"Year": "2010", "Month": "9", "Day": "11", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["20487222", "10.1211/jpp.62.03.0013", "JPHP374"]}}], "PubmedBookArticle": []}